Sign in

Friedreich ataxia: trials that stopped early

Trials on Friedreich ataxia that stopped early, each with the reason the sponsor wrote in the registry, quoted word for word. Next to them: finished trials whose registry record links a result paper.

Stopped early

4 stopped trials give a reason in the registry, latest registry update first.

  1. Terminated

    A Study to Assess Nomlabofusp in Adolescents and Children With Friedreich's Ataxia

    Reason given in the registry

    “Review of Cohort 1 data facilitated direct enrollment into open label study and eliminate pause in study drug administration between PK study and open label study.”

    Quoted unchanged from ClinicalTrials.gov; record updated 10 Jul 2026.

    Ended
    Apr 2025
    Phase
    Phase 1
    Run by
    Larimar Therapeutics, Inc.
    Registry record
    NCT06681766
  2. Withdrawn

    A Study of ASP2016 in Adults Who Have Heart Disease Associated With Friedreich Ataxia

    Reason given in the registry

    “Corporate decision to withdraw the trial at this time.”

    Quoted unchanged from ClinicalTrials.gov; record updated 28 Nov 2025.

    Ended
    Oct 2025
    Phase
    Phase 1
    Run by
    Astellas Gene Therapies
    Registry record
    NCT06483802
  3. Withdrawn

    Understanding the Natural History Early in the Course or Presentation of Friedreich Ataxia

    Reason given in the registry

    “Lack of Funding”

    Quoted unchanged from ClinicalTrials.gov; record updated 8 Jun 2025.

    Run by
    Friedreich's Ataxia Research Alliance
    Registry record
    NCT06560346
  4. Withdrawn

    Study of the Efficacy and Safety of Nicotinamide in Patients With Friedreich Ataxia

    Reason given in the registry

    “Due to a temporary halt the recruitment start was delayed. A re-evaluation of the sponsor revealed, that the study is no longer feasible due to increased administrative and financial requirements.”

    Quoted unchanged from ClinicalTrials.gov; record updated 24 Jan 2024.

    Ended
    Dec 2025
    Phase
    Phase 2
    Run by
    RWTH Aachen University
    Registry record
    NCT03761511

Sources: ClinicalTrials.gov and the EU Clinical Trials Register. Status, reason, dates and result links are registry fields, shown as the registry gives them.